Total Visits

Views
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial103

Total Visits Per Month

January 2020February 2020March 2020April 2020May 2020June 2020July 2020
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial2231131

File Downloads

Views
PIIS0002870317301497.pdf111

Top country views

Views
United States45
Germany18
France11
China6
United Kingdom5
India4
Brazil3
Ireland2
Canada1
Czech Republic1

Top cities views

Views
Ashburn30
Fairfield5
Boardman4
Hyderabad4
Oakland3
Beijing2
Fuzhou2
Boquete1
Chernivtsi1
Dublin1